News & Updates

Show Multimedia Only

Haemostatic powder spray safely stops acute upper GI bleeds in children

29 Aug 2024 by

The use of a powder agent, either as monotherapy or in combination with other conventional therapy, appears to be safe and effective for endoscopic haemostasis in children with acute upper gastrointestinal (GI) bleeding (UGIB), according to real-world data from Singapore.

29 Aug 2024

Dad’s preconception HBV infection tied to baby’s heart defects

28 Aug 2024 by

A preconception history of hepatitis B virus (HBV) infection among fathers carries an increased risk of congenital heart disease (CHD) in offspring, as shown in a study.

28 Aug 2024

Gestational diabetes linked to altered gut microbiome and larger head circumference in male offspring

28 Aug 2024 by

Gestational diabetes mellitus (GDM) not only disrupts the gut microbiome of mothers and their infants, but is also linked to increased head circumference in male offspring, researchers from the Chinese University of Hong Kong (CUHK) have shown.

28 Aug 2024

AI helps spot HCC sooner

23 Aug 2024 by

A novel artificial intelligence (AI) classifier can detect hepatocellular carcinoma (HCC) signatures in routine blood tests up to 1 year before clinical diagnosis, as shown in a study from Hong Kong.

23 Aug 2024

Standardized guidelines missing for treatment of GILCNEC

23 Aug 2024 by

Patients with gastrointestinal large cell neuroendocrine carcinoma (GILCNEC) show varying prognosis depending on the site of the primary tumour, suggests a study. Unfortunately, there remains no standardized consensus guidelines to manage GILCNEC.

23 Aug 2024

Neoadjuvant regorafenib, nivolumab, SCRT combination looks good for rectal cancer

22 Aug 2024 by

Treatment with the combination of regorafenib, nivolumab, and short-course radiotherapy (SCRT) in the neoadjuvant setting has induced response in stage II-III rectal adenocarcinoma in the phase II REGINA trial, meeting the predefined statistical criteria.

22 Aug 2024

Tofacitinib as safe as other biologics in UC patients undergoing colectomy

22 Aug 2024 by

Preoperative treatment with tofacitinib results in adverse events (AEs) rates in the postoperative setting that are similar to that with biologic therapy among patients with ulcerative colitis (UC) undergoing colectomy, a study has shown.

22 Aug 2024

G-EYE improves polyp, adenoma, and serrated polyp detection in colonoscopy

19 Aug 2024

The G-EYE tool helps enhance the polyp (PDR), adenoma (ADR), and serrated polyp detection rates (SPDR) during colonoscopy, suggest the results of a meta-analysis.

19 Aug 2024

Add-on olanzapine augments nausea, vomiting control during chemo cycles

14 Aug 2024 by

Adding olanzapine to prophylactic antiemetic medications appeared to substantially improve nausea and vomiting control among patients receiving moderately emetogenic chemotherapy (MEC) regimens in a phase III randomized clinical trial.

14 Aug 2024

Chemo plus liver transplant prolongs survival in unresectable colorectal liver metastases

13 Aug 2024 by

Liver transplantation (LT) in combination with chemotherapy, as opposed to chemotherapy alone, can provide a meaningful improvement in survival among patients with unresectable colorectal liver metastases, suggest the results of the TRANSMET trial presented at ESMO GI 2024.

13 Aug 2024